Skip to main content

Parkinson's Genetics: How What We're Learning Is Transforming Drug Development

February 16, 2017

In this hour, our panelists discussed what we know about genetic mutations associated with Parkinson's and how growing understanding is helping us develop and test targeted therapies that may slow or stop progression.


Webinar Details

Date:

Thursday, February 16, 2017

Duration:

1 hr

Time:

12:00 pm ET

  • MJFF offers Continuing Medical Education (CME) credit for practicing health care professionals for each Third Thursday Webinar. Click the link in the Resource List after viewing the webinar to take the post-test survey and receive your CME credit.

    Date of Original Release: February 16, 2017
    Date CME Credit No Longer Available: February 16, 2019

    Learning Objectives

    Posting before the live event

    Target Audience

    This educational activity is designed for primary care physicians, family practice physicians, general medicine physicians, geriatricians, general neurologists, movement disorder specialists and any other health care practitioners who manage patients with Parkinson's disease.

    Accreditation

    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Oakstone Publishing, LLC and The Michael J. Fox Foundation for Parkinson's Research. The Oakstone Publishing, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Oakstone Publishing, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Disclosure

    Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing, LLC's planners, content reviewers, and editorial staff disclose no relevant commercial interests.

    Faculty

    Dave Iverson
    Moderator
    No disclosures

    Rachel Saunders-Pullman, MD, MPH
    Associate Professor of Neurology
    Mount Sinai Beth Israel Medical Center
    Research-Grants: Gaucher Generations Program from Genzyme-Sanofi

    Deborah Raymond, MS, CGC
    Genetics Counselor
    Mount Sinai Beth Israel Medical Center
    No disclosures

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.